Michael Brunner

2.7k total citations
75 papers, 1.5k citations indexed

About

Michael Brunner is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Michael Brunner has authored 75 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Cardiology and Cardiovascular Medicine, 31 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Michael Brunner's work include Cardiac electrophysiology and arrhythmias (42 papers), Cardiac pacing and defibrillation studies (26 papers) and Cardiac Arrhythmias and Treatments (24 papers). Michael Brunner is often cited by papers focused on Cardiac electrophysiology and arrhythmias (42 papers), Cardiac pacing and defibrillation studies (26 papers) and Cardiac Arrhythmias and Treatments (24 papers). Michael Brunner collaborates with scholars based in Germany, United States and Switzerland. Michael Brunner's co-authors include Bruce L. Wilkoff, Oussama M. Wazni, Khaldoun G. Tarakji, Katja E. Odening, Manfred Zehender, Gideon Koren, Walid I. Saliba, Bryan Baranowski, Edmond M. Cronin and David O. Martin and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Michael Brunner

68 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Brunner Germany 23 1.2k 475 220 120 104 75 1.5k
K. Neumann Germany 15 495 0.4× 403 0.8× 236 1.1× 155 1.3× 70 0.7× 75 1.2k
Frank Bode Germany 24 1.8k 1.4× 255 0.5× 193 0.9× 40 0.3× 86 0.8× 66 2.0k
Gregory Webster United States 16 559 0.5× 171 0.4× 131 0.6× 130 1.1× 23 0.2× 63 747
Elisa Carturan Italy 17 1.0k 0.8× 179 0.4× 174 0.8× 143 1.2× 15 0.1× 39 1.2k
Lawrence Rosenthal United States 18 651 0.5× 132 0.3× 197 0.9× 91 0.8× 30 0.3× 46 1.1k
N.R. Banner United Kingdom 18 446 0.4× 115 0.2× 431 2.0× 61 0.5× 50 0.5× 34 883
L. Davis Australia 14 571 0.5× 537 1.1× 107 0.5× 16 0.1× 50 0.5× 30 960
Jussi Sipilä Finland 17 380 0.3× 79 0.2× 152 0.7× 165 1.4× 149 1.4× 70 1.0k
Daniel A. Castellanos United States 14 145 0.1× 123 0.3× 213 1.0× 130 1.1× 165 1.6× 51 774
Oren Feldman Israel 8 283 0.2× 639 1.3× 169 0.8× 23 0.2× 283 2.7× 16 915

Countries citing papers authored by Michael Brunner

Since Specialization
Citations

This map shows the geographic impact of Michael Brunner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Brunner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Brunner more than expected).

Fields of papers citing papers by Michael Brunner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Brunner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Brunner. The network helps show where Michael Brunner may publish in the future.

Co-authorship network of co-authors of Michael Brunner

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Brunner. A scholar is included among the top collaborators of Michael Brunner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Brunner. Michael Brunner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brunner, Michael, et al.. (2025). Tricuspid Valve Blood Cysts on Intracardiac Echocardiography. CASE. 9(3). 101–106.
2.
Cruz, Alicia de la, Gideon Koren, Manfred Zehender, et al.. (2025). Beneficial action potential duration–shortening effects, but deleterious negative inotropism of IKs-activator docosahexaenoyl glycine in long QT syndrome type 2. EP Europace. 27(9). 1 indexed citations
3.
Bódi, Ilona, Ibrahim El‐Battrawy, Heiko Bugger, et al.. (2024). Beneficial normalization of cardiac repolarization by carnitine in transgenic short QT syndrome type 1 rabbit models. Cardiovascular Research. 120(13). 1550–1561.
4.
Loyaga‐Rendon, Renzo Y., Michael Brunner, Charles L. Willekes, et al.. (2024). Four-year follow-up of outcomes of the hybrid epicardial-endocardial ablation: A single-center experience. Heart Rhythm. 21(9). 1555–1561. 1 indexed citations
5.
Chalfoun, Nagib, John P. Fox, Michael Brunner, et al.. (2022). A cost comparison of atrial fibrillation monitoring strategies after embolic stroke of undetermined source. SHILAP Revista de lepidopterología. 21. 100195–100195. 2 indexed citations
6.
Wülfers, Eike M., Marina Rieder, Gideon Koren, et al.. (2021). Docosahexaenoic acid normalizes QT interval in long QT type 2 transgenic rabbit models in a genotype-specific fashion. EP Europace. 24(3). 511–522. 8 indexed citations
7.
Rieder, Marina, et al.. (2021). Transgenic rabbit models for cardiac disease research. British Journal of Pharmacology. 179(5). 938–957. 16 indexed citations
8.
Franke, Gerlind, László Hiripi, Gideon Koren, et al.. (2020). Transgenic LQT2, LQT5, and LQT2‐5 rabbit models with decreased repolarisation reserve for prediction of drug‐induced ventricular arrhythmias. British Journal of Pharmacology. 177(16). 3744–3759. 17 indexed citations
9.
Barakat, Amr F., Oussama M. Wazni, Khaldoun G. Tarakji, et al.. (2017). Transvenous lead extraction at the time of cardiac implantable electronic device upgrade: Complexity, safety, and outcomes. Heart Rhythm. 14(12). 1807–1811. 24 indexed citations
10.
Hussein, Ayman A., Oussama M. Wazni, Michael Brunner, et al.. (2016). Microbiology of Cardiac Implantable Electronic Device Infections. JACC. Clinical electrophysiology. 2(4). 498–505. 79 indexed citations
11.
Hussein, Ayman A., Khaldoun G. Tarakji, David O. Martin, et al.. (2016). Cardiac Implantable Electronic Device Infections. JACC. Clinical electrophysiology. 3(1). 1–9. 58 indexed citations
12.
Odening, Katja E., Bernd Jung, Corinna N. Lang, et al.. (2013). Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits. Heart Rhythm. 10(10). 1533–1541. 35 indexed citations
13.
Brunner, Michael, Svati H. Shah, Damian M. Craig, et al.. (2011). EFFECT OF HEPARIN ADMINISTRATION ON METABOLOMIC PROFILES FROM SAMPLES OBTAINED DURING CARDIAC CATHETERIZATION. Journal of the American College of Cardiology. 57(14). E1147–E1147. 2 indexed citations
14.
Odening, Katja E., Lorraine Schofield, Michael Brunner, et al.. (2010). Abstract 15600: Mechanisms of Anti-Arrhythmic Effects of Progesterone and Pro-Arrhythmic Effects of Estradiol in Transgenic Long QT Type 2 Rabbits. Circulation. 122.
15.
Odening, Katja E., Stefan Asbach, Gideon Koren, et al.. (2010). Nicorandil normalizes prolonged repolarisation in the first transgenic rabbit model with Long-QT syndrome 1 both in vitro and in vivo. European Journal of Pharmacology. 650(1). 309–316. 14 indexed citations
16.
Bentzen, Bo Hjorth, Anders Peter Larsen, Katja E. Odening, et al.. (2010). Pharmacological Activation of Kv11.1 in Transgenic Long QT-1 Rabbits. Journal of Cardiovascular Pharmacology. 57(2). 223–230. 31 indexed citations
17.
Odening, Katja E., Jeanne M. Nerbonne, Christoph Bode, Manfred Zehender, & Michael Brunner. (2009). In Vivo Effect of a Dominant Negative Kv4.2 Loss-of-Function Mutation Eliminating I_ on Atrial Refractoriness and Atrial Fibrillation in Mice(Arrhythmia/Electrophysiology). Japanese Circulation Journal-english Edition. 73(3). 461–467. 1 indexed citations
18.
Zehender, Manfred, et al.. (2000). Akute Myokardischämie und ventrikuläre Arrhythmien in der Pathogenese des plötzlichen Herztodes bei koronarer Herzkrankheit. Zeitschrift für Kardiologie. 89(3). 13–23. 3 indexed citations
19.
Brunner, Michael, Thomas Faber, Bärbel Greve, et al.. (2000). Usefulness of Carvedilol in unstable angina pectoris. The American Journal of Cardiology. 85(10). 1173–1178. 9 indexed citations
20.
Müllner, Marcus, F. Sterz, Michael Binder, et al.. (1996). Creatine kinase and creatine kinase-MB release after nontraumatic cardiac arrest. The American Journal of Cardiology. 77(8). 581–585. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Neumann Breakdown of academic impact, for papers by Frank Bode Breakdown of academic impact, for papers by Gregory Webster Breakdown of academic impact, for papers by Elisa Carturan Breakdown of academic impact, for papers by Lawrence Rosenthal Breakdown of academic impact, for papers by N.R. Banner Breakdown of academic impact, for papers by L. Davis Breakdown of academic impact, for papers by Jussi Sipilä Breakdown of academic impact, for papers by Daniel A. Castellanos Breakdown of academic impact, for papers by Oren Feldman
Rankless by CCL
2026